Important Safety Information Prescribing Information This website is intended for US residents only.
Sancuso Logo

SANCUSO® (granisetron transdermal system) Patient RX Solutions

A comprehensive resource committed to supporting patient access to SANCUSO

Patient Rx Solutions logo

Patient RX Solutions helps patients get the prevention of chemotherapy-induced nausea and vomiting they need with:

Prior authorization in 3 easy steps

  1. Enroll: Create your secure account in our online portal to work with a dedicated pharmacy team personally handling your request
  2. Track: Access real-time status reporting of your prior authorization approval process on the website and receive e-mail or fax updates upon your request
  3. Fulfill: Once approved, the Kyowa Kirin products you prescribed can be shipped directly to your patient’s home, your practice, or dispensed from the pharmacy of your choice

For help

For help

Visit Patient RX Solutions to learn more or call 1-800-6-SOLUTIONS (1-800-676-5884)

For help

Co-pay

Click to learn more

Your patients could save up to $300 per patch on SANCUSO after paying the first $20 per prescription (maximum $1200 per month for 4 or more patches)

Click to learn more

Talk to a sales rep

Talk to a sales rep

Contact a sales representative to learn more about how SANCUSO may be able to help

Talk to a sales rep

Request a sample

You may have patients with chemotherapy-induced nausea and vomiting (CINV) who are appropriate for SANCUSO. Request a sample at no cost to see if SANCUSO is the right option for your patients.

Request Sample

Connect to stay informed

You may have patients with CINV who are ready for SANCUSO. Now you can receive updates about SANCUSO and learn about new resources as they become available.

Stay Informed
  1. The copay assistance offer is not valid for prescriptions under Medicaid, a Medicare drug benefit plan, Veterans Administration, DOD, Tricare, or other federal or state programs (such as medical assistance programs). If you are eligible for drug benefits under any such program, you cannot receive this offer. Program managed by PSKW, LLC on behalf of Kyowa Kirin, Inc. The parties reserve the right to amend or end this program at any time. Product dispensed pursuant to program rules and federal and state laws.
Indication and Important Safety Information

Indication

SANCUSO® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.

Important Safety Information

Contraindications

SANCUSO is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch.

Warnings and Precautions

Adverse Reactions

The most common adverse reaction in patients receiving SANCUSO is constipation (5.4%).

To report suspected adverse reactions, contact Kyowa Kirin, Inc. at 1-800-SANCUSO or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See full Prescribing Information for SANCUSO.